Researcher biography

Dr Daniel Liang-Dar Hwang is a member of the Genomic Medicine Program at the University of Queensland Diamantina Institute. He studied Biochemistry as an undergraduate at the National Taiwan University and a Masters in Biotechnology at the University of Pennsylvania. Following graduation, he conducted research at the Monell Chemical Senses Center where he first developed a keen interest in genetics and the perception of smell and taste. Later he secured a scholarship from the University of Washington to complete a Masters in Nutrition and a QIMR Berghofer PhD scholarship to complete a PhD in Genetic Epidemiology. Dr Hwang applies statistical methodologies to twins and large-scale genetic data to understand how genes influence human perception, dietary behaviour and related chronic disorders (e.g., obesity, cardiometabolic disease and cancer). He has published in top-tier journals, including the American Journal of Clinical Nutrition, International Journal of Epidemiology, and PLOS Genetics, with a total of 30 peer-review publications. He is on the editorial boards of the Twin Research and Human Genetics, the Frontiers in Genetics and the Frontiers in Psychiatry. Dr Hwang's current research focuses on developing statistical genetic methods for personalized intervention and family-based Mendelian randomization. He also works with clinicians to study cancer treatment-induced taste distortion with an aim to improve patients' quality of life. Dr Hwang co-chairs the translation team in the Global Consortium for Chemosensory Research where he coordinates the translation of online surveys on the COVID-19 pandemic, which have been available in >30 languages and completed by >45k participants around the world. Dr Hwang aims to translate research findings into practice. His work has been referred in a major U.S. health policy guideline and a WHO report for the intervention of childhood obesity and cited in an international patent for personalized wine selection.